Japan research supports use of Ivermectin

 PJ Media:

Anti-parasite drug Ivermectin shows an “antiviral effect” against omicron and other COVID variants according to research released Monday by Japanese pharmaceutical giant Kowa.

According to Reuters, the firm has been working with Tokyo’s Kitasato University.

While Reuters described the study as “non-clinical,” last June the American Journal of Therapeutics published a meta-analysis of 15 different clinical studies.

That AJT analysis concluded:

Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.

The next month, podcast star Joe Rogan took Ivermectin to treat himself for COVID with well-known positive results — something NBC News at the time called a “widely discredited drug.”

That same AJT analysis remarked that “Ivermectin has exhibited antiviral activity against a wide range of RNA and some DNA viruses,” which would seem to be in line with today’s news out of Japan.

...

This could explain why families are sneaking it into patients who are near death.  It is apparently most effective in the early treatment of the virus.  I noticed that Facebook has in the past indicated that this off use could be dangerous without indicating what the effects were.

See, also:

146 Research Studies Affirm Naturally Acquired Immunity to COVID-19

Comments

Post a Comment

Popular posts from this blog

Should Republicans go ahead and add Supreme Court Justices to head off Democrats

Washington Post: Some Democrats eye adding more justices to the Supreme Court to change its ideological bent The once-remote idea has gained the attention of liberals angered by the GOP push to remake the federal courts. Probably the easy way to defeat this court-packing scheme is for Trump to propose doing the same thing now.  It would lead to Democrat denunciations and claims that it would be wrong, thereby blowing up any attempt by them in the unfortunate event of Democrats winning a presidential election.
Read more

29 % of companies say they are unlikely to keep insurance after Obamacare

Conn Carroll: A new survey of 368 midsize to large companies found that 29% of them are considering terminating their active employee health care plans when Obamacare is full implemented in 2014. Only 71% of employers surveyed said they did not expect to drop their health coverage, while 20% said they did not know and 9% said they were planning to exit. The latest survey, conducted by Towers Watson, echoes an ealier survey by McKinsey & Co. finding that 30% of private-sector employers were planning to drop their employee health insurance coverage by 2014. When the Congressional Budget Office crunched Obamacare's spending numbers, they estimated that only 7% of employees currently covered by employer-sponsored plans would lose their plans. ... This means the cost of the health care fiasco will be hundreds of billions more than estimated by the CBO and Congressional Democrat. It is also clear that Obama's pledge that you could keep your health care plan if you wanted t
Read more